|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Linda ElsegoodPublisher: LDN Research Trust Imprint: LDN Research Trust ISBN: 9781739107048ISBN 10: 1739107047 Pages: 252 Publication Date: 06 June 2024 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Available To Order We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationLinda Elsegood discovered LDN after relapsing/remitting MS, which caused her to have attacks every six months. It took months for a relapse to recede, only to have another begin. In October 2003, Linda was advised she had secondary progressive MS and there was nothing anyone could do to help her, and like so many people sought alternative options for her own healthcare. Following her success with LDN, Linda Elsegood founded the LDN Research Trust as a UK nonprofit registered charity in 2004. The LDN Research Trust (www.ldnresearchtrust.org) is run by volunteers; they receive no funding and rely on donations. The team liaises closely with prescribers, pharmacists, and patients, offering support and education. The charity's website has become a go-to resource for patients and medical professionals seeking the latest information on clinical trials and studies involving LDN, conditions for which LDN is used, global LDN prescribers and pharmacists, prescriber/patient guides, and more. They have their own LDN Radio Show, which listeners can access on Mixcloud, Captivate FM, Google, Apple & Amazon Podcast, iTunes, and Spotify in addition to Vimeo and YouTube. Six documentaries have also been produced with significant reach and success. In June 2023, the LDN Research Trust annual LDN conference will be held in the United States, and seminars, workshops and smaller events are arranged regularly to help build awareness and education, and to encourage and support ongoing research about LDN. Tab Content 6Author Website:Countries AvailableAll regions |
||||